Market Report, "Oman Pharmaceuticals & Healthcare Report Q3 2014", Published
Oman's strong demand for patented innovative drugs, driven by its traditional wealth, especially among the sizeable expatriate community, will continue to attract multinational company investment. Although a relatively small market in comparison with the rest of the Gulf Cooperation Council, high growth rate estimates over the next decade, the country's growing and ageing population and a rapid increase in non-communicable diseases provide opportunities for high returns on investment.
View full press release